| scholarly article | Q13442814 |
| P2093 | author name string | Lawrence Ginsberg | |
| Amir H Kalali | |||
| Richard H Weisler | |||
| Andrew J Cutler | |||
| Thomas D Gazda | |||
| P2860 | cites work | A rating scale for depression | Q24564540 |
| A New Depression Scale Designed to be Sensitive to Change | Q29614720 | ||
| A rating scale for mania: reliability, validity and sensitivity | Q29619299 | ||
| The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study | Q33850634 | ||
| Systematic overview of lithium treatment in acute mania | Q33905283 | ||
| Historical perspectives and natural history of bipolar disorder | Q33920209 | ||
| Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review | Q33988376 | ||
| Comparative efficacy and tolerability of drug treatments for bipolar disorder | Q34387550 | ||
| Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies | Q34558705 | ||
| Medical management of obesity associated with mental disorders. | Q34576869 | ||
| Iatrogenic disorders associated with conventional vs. atypical antipsychotics | Q34604270 | ||
| Valproate in the treatment of acute mania. A placebo-controlled study | Q34613045 | ||
| Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group | Q34727272 | ||
| Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder. | Q34744028 | ||
| Mood stabilizer combinations: a review of safety and efficacy | Q34744469 | ||
| Combination treatment in bipolar disorder: a review of controlled trials | Q35142745 | ||
| Polytherapy in bipolar disorder | Q36361982 | ||
| Safety of carbamazepine extended-release capsules in bipolar disorder polypharmacy | Q36497653 | ||
| Cost-effectiveness of rosiglitazone combination therapy for the treatment of type 2 diabetes mellitus in the UK. | Q36519203 | ||
| The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials | Q36606791 | ||
| Delapril plus indapamide: a review of the combination in the treatment of hypertension | Q36824038 | ||
| Patient and physician attitudes toward lithium: relationship to compliance | Q41666337 | ||
| Maintenance lithium treatment: side effects and compliance | Q42203247 | ||
| Relapse and impairment in bipolar disorder | Q43514252 | ||
| Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy | Q43846648 | ||
| Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety | Q44045819 | ||
| A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania | Q44168457 | ||
| The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype | Q44207549 | ||
| Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial | Q44299951 | ||
| Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial | Q44385585 | ||
| Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study | Q44495168 | ||
| A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 | ||
| Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study | Q44874572 | ||
| A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. | Q44877765 | ||
| Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial | Q44915194 | ||
| Importance of Psychiatric Diagnosis in Prediction of Clinical Drug Effects | Q44993702 | ||
| Demographic and clinical characteristics of individuals in a bipolar disorder case registry | Q45027844 | ||
| Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. | Q46377270 | ||
| Perceptions of weight gain and bipolar pharmacotherapy: results of a 2005 survey of physicians in clinical practice | Q46687256 | ||
| Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials | Q46984808 | ||
| Psychotropic drug prescription patterns among patients with bipolar I disorder. | Q52066927 | ||
| Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. | Q52900826 | ||
| Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil. | Q53286996 | ||
| Correlates of overweight and obesity in 644 patients with bipolar disorder | Q60646356 | ||
| Carbamazepine in manic-depressive illness: a new treatment | Q71229902 | ||
| Factors predicting the use of multiple psychotropic medications | Q72536204 | ||
| Prevalence of overweight and obesity in bipolar patients | Q73805994 | ||
| P433 | issue | 5 | |
| P921 | main subject | carbamazepin | Q410412 |
| P304 | page(s) | 49-60 | |
| P577 | publication date | 2008-05-01 | |
| P1433 | published in | Psychiatry | Q26842839 |
| P1476 | title | Safety of carbamazepine extended-release capsules used in combination with other psychotropic medications for the treatment of bipolar I disorder | |
| P478 | volume | 5 |
| Q52661474 | Possible Pharmacodynamic and Pharmacokinetic Drug-Drug Interactions That Are Likely to Be Clinically Relevant and/or Frequent in Bipolar Disorder. | cites work | P2860 |
Search more.